Health Trials

NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study

ConditionsGastro-Intestinal DisorderCrohn DiseaseUlcerative ColitisInflammatory Bowel Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorUniversity of Nottingham

About this trial

The goal of this observational study is to learn about the comparisons of inflammatory markers between IBD and non-IBD (control) participants.

The main question it aims to answer is:

Are there differences in inflammatory markers between IBD and non-IBD (control) participants.

Eligibility criteria

Qualifiers

None

Disqualifiers

Inability to give informed consent

Any positive result from previous screening for serum hepatitis B surface antigen, hepatitis C or human immunodeficiency virus (HIV)

An ongoing infection requiring treatment

Clinical evidence of active COVID infection and/or evidence of active COVID determined by local standard care procedures

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

240 Participants
are grouped into 6 trial groups

6

Trial groups

See each trial group below.

Sponsors and collaborators

University of Nottingham

Lead sponsor

Nottingham University Hospitals NHS Trust

Collaborator

Source ClinicalTrials.gov